Physiochemical and functional evaluation of the first-in-class anti-cancer IgE antibody drug, MOv18, through process development and good manufacturing practice production.
通过工艺开发和良好生产规范生产,对首创抗癌 IgE 抗体药物 MOv18 进行理化和功能评价。
期刊:MAbs
影响因子:7.3
doi:10.1080/19420862.2025.2451295
Bax Heather J, Chauhan Jitesh, McCraw Alexandra J, Grandits Melanie, Stavraka Chara, Lentfer Heike, Hillyer Tim, Carroll Simon, Vigor Kim, Selkirk Chris, Figini Mariangela, Cheeseman Jack, Urbanowicz Paulina A, Gardner Richard A, Spencer Daniel I R, Westwood Nigel, Mellor Sarah, Spicer James, Josephs Debra H, Karagiannis Sophia N